Anaptysbio, Inc.
Records under this name other than the patents Anaptysbio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,685,897 | Methods of Generating Libraries and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,260,533 | Methods of Generating Libraries and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,637,556 | Methods of Generating Libraries and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,603,950 | Methods of Generating Libraries and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,328,166 | Antibodies Directed Against IL-17 Formerly held In force · High confidence | In force | High confidence | |
| US 8,926,978 | Antibodies Directed Against Nerve Growth Factor (NGF) Formerly held In force · High confidence | In force | High confidence | |
| US 9,951,126 | Antibodies Directed Against Nerve Growth Factor (NGF) Formerly held In force · High confidence | In force | High confidence | |
| US 9,133,269 | Humanized Antibodies Directed Against Complement Protein C5 Formerly held In force · High confidence | In force | High confidence | |
| US 10,059,764 | Antibodies Directed Against INTERLEUKIN-33 (IL-33) and Methods of Making and Using Formerly held In force · High confidence | In force | High confidence | |
| US 10,836,820 | Method of Treating Inflammatory Disorder with Antibodies Directed Against INTERLEUKIN-33 (IL-33) Formerly held In force · High confidence | In force | High confidence |